Latest press releases, media assets and global media contacts
Scroll to explore
Search our corporate press releases by keyword or date. You can also visit our market websites for press releases from our local operating companies.
Explore our images and videos for use in the media.
Latest news and reports
2022 Full year and fourth quarter results announcementQuarterly results
We announced our full year and fourth quarter results for the period ended 31 December 2022 on Wednesday 1 February.
Our response to the situation in UkraineLearn more
Alongside the global community, we share deep concern about the tragic events happening in Ukraine. We are taking actions guided by our purpose, and as a company dedicated to health and care for people and patients.
Our response to Covid-19Learn more
Since the pandemic began, we have sought ways to harness our scientific expertise and technology to make a difference. Together with our partners we are developing COVID-19 therapeutics and vaccines, and now have assets at various stages of development, including two approved for use (in some markets).
GSK on Twitter
Meet our 2023 #GSKIMPACTUK Award winner @CroydonBMEForum, working to tackle health inequalities and improve the physical and mental health of ethnic minority communities in Croydon. Learn more 👉cbmeforum.org5hTwitter @GSK Apr 01
Meet our 2023 #GSKIMPACTUK Award winner @CellarTrust, providing mental health services to support people in Bradford District and Craven. Want to know more? 👉thecellartrust.orgksTwitter @GSK Apr 01
At approximately what age does the adult immune system become depleted of the resilience built up in youth?Twitter @GSK Mar 31
#News for #Investors and #Media Today we’ve entered into an exclusive licence agreement with @scynexis. This agreement complements GSK’s infectious diseases portfolio and builds on our commitment to get ahead of AMR. Find out more: gsk.to/3zh3XY2Twitter @GSK Mar 30
#News for #Investors and #Media: Today @ViiVHC, our specialist HIV company, have announced progress in their commitment to voluntary licencing for populations with unmet needs. Find out more: gsk.comTwitter @GSK Mar 30
Scientists are turning to an array of novel approaches to try to prevent life-threatening diseases – including vaccine technologies like MAPS. gsk.to/40qx8UKTwitter @GSK Mar 29
Thank you, @IMFmyeloma, for leading another meaningful #MyelomaActionMonth! 🩸❤️ We’re inspired by those who shared their#MYelomaSTORYY and proud to support this community alongside dedicated advocacy partners like@LLSusaa,@theMMRFF and@HealthTreee.Twitter @GSK Mar 28
#News for #Investors and #Media: today at #SGOmtg, we shared promising data from our #cancer research programmes. Learn more.Twitter @GSK Mar 27
Meet our 2023 #GSKIMPACTUK Award winner @Brthcompanions, supporting and empowering women facing inequality and disadvantage during pregnancy, birth and early motherhood. Learn more here 👇birthcompanions.org.ukKMTwitter @GSK Mar 25
Meet our 2023 #GSKIMPACTUK Award winner @AuroraNewDawn, supporting victims and survivors of domestic abuse, sexual violence and stalking. Want to know more? 👉aurorand.org.ukVETwitter @GSK Mar 25